| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers N > Headlines for Neurogen Corp. > News item |
Millenco owns 4.5% of Neurogen
By Lisa Kerner
Charlotte, N.C., June 18 - Neurogen Corp. investors led by Millenco LLC reported beneficial ownership of 1,865,201 shares, or 4.5%, of the Branford, Conn., drug development company's outstanding stock.
Millenco bought and sold a number of shares in a series of transactions from April 16 to June 15, with the shares priced from $6.87 to $8.71, according to a schedule 13D filing with the Securities and Exchange Commission.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.